
Investornewsbreaks Zacks Research Releases Updated Report As Soligenix Inc. (NASDAQ: SNGX) Eyes Upcoming 'Key Catalysts'...
(MENAFN- Investor Brand Network) Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company targeting rare diseases, was spotlighted in a July 10 Zacks Small-Cap Research report that presented a favorable analysis, noting that the company is …